<?xml version="1.0" encoding="UTF-8"?>
<p id="Par54">The sex-biased mortality from COVID-19 suggests that research should be focused on identifying sex-related differences associated with physiology, immune function, and developmental processes. Fewer female animals are used in research and clinical trials and that the preferred choice of models remains males [
 <xref ref-type="bibr" rid="CR100">100</xref>, 
 <xref ref-type="bibr" rid="CR101">101</xref>]. The inclusion of both males and females in research is needed to bridge the gap of drug discovery, drug toxicity, and pathogenesis.
</p>
